233 related articles for article (PubMed ID: 36531507)
21. Biochemical Diagnosis of Catecholamine-Producing Tumors of Childhood: Neuroblastoma, Pheochromocytoma and Paraganglioma.
Eisenhofer G; Peitzsch M; Bechmann N; Huebner A
Front Endocrinol (Lausanne); 2022; 13():901760. PubMed ID: 35957826
[TBL] [Abstract][Full Text] [Related]
22. Plasma free metanephrines for diagnosis of neuroblastoma patients.
Barco S; Verly I; Corrias MV; Sorrentino S; Conte M; Tripodi G; Tytgat G; van Kuilenburg A; van der Ham M; de Sain-van der Velden M; Garaventa A; Cangemi G
Clin Biochem; 2019 Apr; 66():57-62. PubMed ID: 30822416
[TBL] [Abstract][Full Text] [Related]
23. Performance of plasma fractionated free metanephrines by enzyme immunoassay in the diagnosis of pheochromocytoma and paraganglioma in children.
Sarathi V; Pandit R; Patil VK; Lia AR; Bandgar TR; Shah NS
Endocr Pract; 2012; 18(5):694-9. PubMed ID: 22982790
[TBL] [Abstract][Full Text] [Related]
24. [Pediatric pheochromocytoma and paraganglioma: an update].
Garnier S; Réguerre Y; Orbach D; Brugières L; Kalfa N
Bull Cancer; 2014 Oct; 101(10):966-75. PubMed ID: 25373696
[TBL] [Abstract][Full Text] [Related]
25. Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines.
Eisenhofer G; Lenders JW; Goldstein DS; Mannelli M; Csako G; Walther MM; Brouwers FM; Pacak K
Clin Chem; 2005 Apr; 51(4):735-44. PubMed ID: 15718487
[TBL] [Abstract][Full Text] [Related]
26. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines.
Sawka AM; Jaeschke R; Singh RJ; Young WF
J Clin Endocrinol Metab; 2003 Feb; 88(2):553-8. PubMed ID: 12574179
[TBL] [Abstract][Full Text] [Related]
27. Quantitation using HRMS: A new tool for rapid, specific and sensitive determination of catecholamines and deconjugated methanephrines metanephrines in urine.
Lefeuvre S; Bois-Maublanc J; Mongeois E; Policarpo V; Formaux L; Francia T; Billaud EM; Got L
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Mar; 1166():122391. PubMed ID: 33246878
[TBL] [Abstract][Full Text] [Related]
28. Pheochromocytoma and abdominal paraganglioma.
Renard J; Clerici T; Licker M; Triponez F
J Visc Surg; 2011 Dec; 148(6):e409-16. PubMed ID: 21862435
[TBL] [Abstract][Full Text] [Related]
29. Plasma free metanephrines are superior to urine and plasma catecholamines and urine catecholamine metabolites for the investigation of phaeochromocytoma.
Hickman PE; Leong M; Chang J; Wilson SR; McWhinney B
Pathology; 2009 Feb; 41(2):173-7. PubMed ID: 19152190
[TBL] [Abstract][Full Text] [Related]
30. Hereditary Diseases Predisposing to Pheochromocytoma (VHL, NF-1, Paraganglioma Syndromes, and Novel Genes).
Sarkadi B; Patócs A
Exp Suppl; 2019; 111():129-147. PubMed ID: 31588531
[TBL] [Abstract][Full Text] [Related]
31. [Biological diagnosis of pheochromocytomas and paragangliomas].
d'Herbomez M; Rouaix N; Bauters C; Wémeau JL
Presse Med; 2009 Jun; 38(6):927-34. PubMed ID: 19135846
[TBL] [Abstract][Full Text] [Related]
32. The noradrenergic profile of plasma metanephrine in neuroblastoma patients is reproduced in xenograft mice models and arise from PNMT downregulation.
Abid K; Popovic MB; Bourloud KB; Schoumans J; Grand-Guillaume J; Grouzmann E; Mühlethaler-Mottet A
Oncotarget; 2021 Jan; 12(1):49-60. PubMed ID: 33456713
[TBL] [Abstract][Full Text] [Related]
33. Pheochromocytoma: rediscovery as a catecholamine-metabolizing tumor.
Eisenhofer G; Goldstein DS; Kopin IJ; Crout JR
Endocr Pathol; 2003; 14(3):193-212. PubMed ID: 14586065
[TBL] [Abstract][Full Text] [Related]
34. Biochemical diagnosis of pheochromocytoma: which test is best?
Lenders JW; Pacak K; Walther MM; Linehan WM; Mannelli M; Friberg P; Keiser HR; Goldstein DS; Eisenhofer G
JAMA; 2002 Mar; 287(11):1427-34. PubMed ID: 11903030
[TBL] [Abstract][Full Text] [Related]
35. Genetics, diagnosis, and management of medullary thyroid carcinoma and pheochromocytoma/paraganglioma.
Moraitis AG; Martucci VL; Pacak K
Endocr Pract; 2014 Feb; 20(2):176-87. PubMed ID: 24449662
[TBL] [Abstract][Full Text] [Related]
36. Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene.
Timmers HJ; Pacak K; Huynh TT; Abu-Asab M; Tsokos M; Merino MJ; Baysal BE; Adams KT; Eisenhofer G
J Clin Endocrinol Metab; 2008 Dec; 93(12):4826-32. PubMed ID: 18840642
[TBL] [Abstract][Full Text] [Related]
37. [Pheochromocytoma and paraganglioma: basics for the general practitioner].
Loosli N; Köhler BB; Pechère-Bertschi A; Karenovics W; Triponex F
Rev Med Suisse; 2014 Sep; 10(441):1650-2, 1654-5. PubMed ID: 25322623
[TBL] [Abstract][Full Text] [Related]
38. Erratum: Low number of neurosecretory vesicles in neuroblastoma impairs massive catecholamine release and prevents hypertension.
Frontiers Production Office
Front Endocrinol (Lausanne); 2023; 14():1172478. PubMed ID: 36967778
[TBL] [Abstract][Full Text] [Related]
39. Advances in catecholamine and metabolite measurements for diagnosis of pheochromocytoma.
Rosano TG; Swift TA; Hayes LW
Clin Chem; 1991 Oct; 37(10 Pt 2):1854-67. PubMed ID: 1914202
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
